These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1163 related items for PubMed ID: 15886253

  • 1. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [Abstract] [Full Text] [Related]

  • 2. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N.
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [Abstract] [Full Text] [Related]

  • 3. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ, Åsvold BO, Eskild A.
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [Abstract] [Full Text] [Related]

  • 4. Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
    Fadigas C, Peeva G, Mendez O, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):191-7. PubMed ID: 25825848
    [Abstract] [Full Text] [Related]

  • 5. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P, Mendoza M, Bonacina E, Garrido-Gimenez C, Fernandez-Oliva A, Zanini J, Catalan M, Tur H, Serrano B, Carreras E.
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [Abstract] [Full Text] [Related]

  • 6. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA.
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [Abstract] [Full Text] [Related]

  • 7. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 8. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
    MacDonald TM, Tran C, Kaitu'u-Lino TJ, Brennecke SP, Hiscock RJ, Hui L, Dane KM, Middleton AL, Cannon P, Walker SP, Tong S.
    BMC Pregnancy Childbirth; 2018 Aug 31; 18(1):354. PubMed ID: 30170567
    [Abstract] [Full Text] [Related]

  • 9. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.
    Tsao PN, Wei SC, Su YN, Chou HC, Chen CY, Hsieh WS.
    Pediatrics; 2005 Aug 31; 116(2):468-72. PubMed ID: 16061605
    [Abstract] [Full Text] [Related]

  • 10. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S, Gallo DM, Mendez O, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Aug 31; 46(2):208-15. PubMed ID: 25826797
    [Abstract] [Full Text] [Related]

  • 11. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S, Peeva G, Gonzalez R, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Oct 31; 46(4):446-51. PubMed ID: 25826154
    [Abstract] [Full Text] [Related]

  • 12. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov 31; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 13. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.
    N Engl J Med; 2004 Feb 12; 350(7):672-83. PubMed ID: 14764923
    [Abstract] [Full Text] [Related]

  • 14. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
    Gurnadi JI, Mose J, Handono B, Satari MH, Anwar AD, Fauziah PN, Yogi Pramatirta A, Rihibiha DD.
    BMC Res Notes; 2015 Oct 04; 8():534. PubMed ID: 26434493
    [Abstract] [Full Text] [Related]

  • 15. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.
    Circulation; 2010 Aug 03; 122(5):478-87. PubMed ID: 20644016
    [Abstract] [Full Text] [Related]

  • 16. Serum placental growth factor and soluble fms-like tyrosine kinase 1 at mid-gestation in healthy women: Association with small-for-gestational-age neonates.
    Furuta I, Umazume T, Kojima T, Chiba K, Nakagawa K, Hosokawa A, Ishikawa S, Yamada T, Morikawa M, Minakami H.
    J Obstet Gynaecol Res; 2017 Jul 03; 43(7):1152-1158. PubMed ID: 28422347
    [Abstract] [Full Text] [Related]

  • 17. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
    Graupner O, Karge A, Flechsenhar S, Seiler A, Haller B, Ortiz JU, Lobmaier SM, Axt-Fliedner R, Enzensberger C, Abel K, Kuschel B.
    Arch Gynecol Obstet; 2020 Feb 03; 301(2):375-385. PubMed ID: 31734756
    [Abstract] [Full Text] [Related]

  • 18. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
    Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, Connor JM, Dobbie R.
    Obstet Gynecol; 2007 Jun 03; 109(6):1316-24. PubMed ID: 17540803
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA.
    J Clin Endocrinol Metab; 2004 Feb 03; 89(2):770-5. PubMed ID: 14764795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.